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Tamoxifen is an anti-estrogen drug which has shown tremendous excellent recovery rate in 
breast cancer treatment. However, after a long term of consumption, patients are prone to 
experience side effects of tamoxifen. These side effects however can be reduced in controlled 
drug delivery, using encapsulation within biodegradable method. Supercritical anti-solvent 
(SAS) process was chosen to synthesize tamoxifen encapsulated in poly-l-lactic using 
supercritical carbon dioxide as the anti-solvent. Conventionally, this encapsulation was 
carried out using processes such as solvent evaporation, spray drying and high pressure 
homogenization process. In SAS process, only a single step precipitation process was 
required to produce encapsulated particles and particles can be directly used upon process 
completion. Techniques such as Fourier transform infrared spectroscopy (FTIR), X-ray 
diffraction (XRD), differential scanning calorimetry (DSC), scanning electron microscopy 
(SEM), and energy dispersive x-ray analysis (EDX) were used to characterize the powder 
from SAS process and compared with raw tamoxifen as a reference. It was noted crystallinity 
of tamoxifen changes from crystalline to amorphous due to rapid precipitation process, but 
thermal properties such as melting point of tamoxifen retains after SAS process. From EDX 
analysis, it was found that no trace of solvent existed in the final product, thus indicating 
solvent was completely removed from the final product of SAS process. 
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